ICU MEDICAL INC (ICUI) Stock Fundamental Analysis
USA - NASDAQ:ICUI - US44930G1076 - Common Stock
130.36 USD
-1.81 (-1.37%)
130.36 USD
0 (0%)
Taking everything into account, ICUI scores 4 out of 10 in our fundamental rating. ICUI was compared to 191 industry peers in the Health Care Equipment & Supplies industry. ICUI has only an average score on both its financial health and profitability. ICUI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ICUI was profitable.
ICUI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
ICUI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ICUI's Return On Assets of -0.90% is fine compared to the rest of the industry. ICUI outperforms 70.16% of its industry peers.
ICUI has a Return On Equity of -1.75%. This is in the better half of the industry: ICUI outperforms 70.68% of its industry peers.
ICUI has a Return On Invested Capital of 2.81%. This is in the better half of the industry: ICUI outperforms 71.20% of its industry peers.
ICUI had an Average Return On Invested Capital over the past 3 years of 1.36%. This is significantly below the industry average of 8.46%.
The last Return On Invested Capital (2.81%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.75% | ||
| ROIC | 2.81% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
ICUI's Operating Margin of 5.43% is fine compared to the rest of the industry. ICUI outperforms 70.68% of its industry peers.
ICUI's Operating Margin has declined in the last couple of years.
ICUI has a worse Gross Margin (35.84%) than 71.73% of its industry peers.
ICUI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.43% | ||
| PM (TTM) | N/A | ||
| GM | 35.84% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
ICUI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ICUI has more shares outstanding
ICUI has a worse debt/assets ratio than last year.
2.2 Solvency
ICUI has an Altman-Z score of 2.10. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.10, ICUI is in the better half of the industry, outperforming 63.35% of the companies in the same industry.
ICUI has a debt to FCF ratio of 26.58. This is a negative value and a sign of low solvency as ICUI would need 26.58 years to pay back of all of its debts.
ICUI has a Debt to FCF ratio of 26.58. This is in the better half of the industry: ICUI outperforms 70.16% of its industry peers.
ICUI has a Debt/Equity ratio of 0.63. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
The Debt to Equity ratio of ICUI (0.63) is worse than 68.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 26.58 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.38
WACC7.43%
2.3 Liquidity
A Current Ratio of 2.44 indicates that ICUI has no problem at all paying its short term obligations.
ICUI has a Current ratio (2.44) which is comparable to the rest of the industry.
A Quick Ratio of 1.17 indicates that ICUI should not have too much problems paying its short term obligations.
ICUI's Quick ratio of 1.17 is on the low side compared to the rest of the industry. ICUI is outperformed by 69.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 32.86% over the past year.
ICUI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.28% yearly.
ICUI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.96%.
ICUI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.47% yearly.
EPS 1Y (TTM)32.86%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%34.62%
Revenue 1Y (TTM)2.96%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-6.44%
3.2 Future
ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.18% yearly.
ICUI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.95% yearly.
EPS Next Y14.6%
EPS Next 2Y15.15%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.95%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.34, which indicates a rather expensive current valuation of ICUI.
Compared to the rest of the industry, the Price/Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 81.15% of the companies listed in the same industry.
ICUI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
Based on the Price/Forward Earnings ratio of 15.81, the valuation of ICUI can be described as correct.
Based on the Price/Forward Earnings ratio, ICUI is valued cheaply inside the industry as 81.68% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, ICUI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.34 | ||
| Fwd PE | 15.81 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ICUI is valued cheaper than 84.82% of the companies in the same industry.
73.82% of the companies in the same industry are more expensive than ICUI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 63.72 | ||
| EV/EBITDA | 12.66 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ICUI's earnings are expected to grow with 15.91% in the coming years.
PEG (NY)1.19
PEG (5Y)N/A
EPS Next 2Y15.15%
EPS Next 3Y15.92%
5. Dividend
5.1 Amount
ICUI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
130.36
-1.81 (-1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners102.26%
Inst Owner Change0.43%
Ins Owners1.14%
Ins Owner Change1.85%
Market Cap3.22B
Analysts83.33
Price Target181.36 (39.12%)
Short Float %5.65%
Short Ratio4.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.5%
Min EPS beat(2)31.74%
Max EPS beat(2)37.25%
EPS beat(4)4
Avg EPS beat(4)33.31%
Min EPS beat(4)24.67%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)30.18%
EPS beat(12)12
Avg EPS beat(12)24.5%
EPS beat(16)15
Avg EPS beat(16)18.53%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.09%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)5
Avg Revenue beat(8)-0.01%
Revenue beat(12)6
Avg Revenue beat(12)-0.81%
Revenue beat(16)8
Avg Revenue beat(16)-0.38%
PT rev (1m)-5.55%
PT rev (3m)-5.55%
EPS NQ rev (1m)0.66%
EPS NQ rev (3m)-4.57%
EPS NY rev (1m)5.3%
EPS NY rev (3m)5.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)-0.58%
Revenue NY rev (3m)-0.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.34 | ||
| Fwd PE | 15.81 | ||
| P/S | 1.36 | ||
| P/FCF | 63.72 | ||
| P/OCF | 23.18 | ||
| P/B | 1.52 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.66 |
EPS(TTM)7.52
EY5.77%
EPS(NY)8.25
Fwd EY6.33%
FCF(TTM)2.05
FCFY1.57%
OCF(TTM)5.62
OCFY4.31%
SpS96.09
BVpS85.69
TBVpS-3.41
PEG (NY)1.19
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.9% | ||
| ROE | -1.75% | ||
| ROCE | 3.56% | ||
| ROIC | 2.81% | ||
| ROICexc | 3.06% | ||
| ROICexgc | 9.06% | ||
| OM | 5.43% | ||
| PM (TTM) | N/A | ||
| GM | 35.84% | ||
| FCFM | 2.13% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexcg growth 3Y-18.09%
ROICexcg growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 26.58 | ||
| Debt/EBITDA | 3.98 | ||
| Cap/Depr | 42.51% | ||
| Cap/Sales | 3.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 41.23% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.1 |
F-Score7
WACC7.43%
ROIC/WACC0.38
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.86%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%34.62%
EPS Next Y14.6%
EPS Next 2Y15.15%
EPS Next 3Y15.92%
EPS Next 5Y17.18%
Revenue 1Y (TTM)2.96%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-6.44%
Revenue Next Year-5.53%
Revenue Next 2Y-3.44%
Revenue Next 3Y-0.82%
Revenue Next 5Y1.95%
EBIT growth 1Y118.78%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year38.33%
EBIT Next 3Y19.87%
EBIT Next 5Y10.07%
FCF growth 1Y216.11%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y243.63%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%